Welcome to our dedicated page for Kneat Com news (Ticker: KSIOF), a resource for investors and traders seeking the latest updates and insights on Kneat Com stock.
kneat.com, inc. develops digital validation and quality process automation software for highly regulated industries. Its Kneat Gx platform is used to manage validation disciplines end to end, with compliance features tied to GxP environments, data integrity, 21 CFR Part 11/Annex 11 requirements, and ISO 9001 and ISO 27001 certification.
Company news commonly covers customer agreements with life sciences, CDMO, pharmaceutical packaging, and biopharma manufacturing organizations; financial results and shareholder communications; platform capabilities including optional AI tools; and the company’s State of Validation research on digitization, validation workload, and compliance practices.
Kneat (OTCQX: KSIOF, TSX: KSI) reported voting results from its May 27, 2026 Annual General Meeting. All five director nominees were elected with support ranging from 96.61% to 99.98% of votes cast. Shareholders also re-appointed KPMG LLP as auditors with 99.99% support, with 51,419,056 votes cast overall.
Kneat (OTCQX:KSIOF) reported Q1 2026 revenue of $18.0 million, up 22% year over year. Gross profit rose 28% to $14.0 million, driving a 78% gross margin. ARR reached $76.4 million, up 20%.
The quarter showed a net loss of $3.9 million versus a prior-year profit, with EBITDA at $0.8 million and Adjusted EBITDA improving to $2.7 million. Kneat highlighted new life sciences customer wins, strong pipeline commentary, and recognition as a G2 leader in pharma and biotech software.
Kneat (TSX: KSI, OTC: KSIOF) acknowledged a press report about a potential strategic review and confirmed that its board has formed a special committee to evaluate strategic alternatives, with CIBC Capital Markets as financial advisor.
The review began in February 2026, and no definitive agreement or transaction has been reached. There is no assurance any transaction will occur. Kneat states it remains focused on its business strategy and shareholder value and does not plan further updates unless a definitive transaction is announced or disclosure becomes required.
Kneat Solutions (OTCQX: KSIOF) published its State of Validation 2026, based on over 600 validation professionals worldwide. The study finds rising validation workloads (80% increased; 45% significant), widespread digital tool adoption but limited full digital maturity (13% fully digital), and growing, human‑reviewed AI use in GxP settings.
Key metrics: 74% of implemented systems met or exceeded ROI expectations; 78% expect AI to be standard in validation by 2030. Paper remains common in core records.
kneat.com (OTCQX: KSIOF) signed a Master Subscription Agreement with one of Europe’s largest CDMOs to digitize equipment validation across more than two dozen production sites. The program targets stronger data integrity, traceability, standardization and improved audit readiness as the CDMO scales validation capacity.
The deal supports the CDMO’s corporate initiative to accelerate validation digitization driven by increased workload and a need for greater operational efficiency and scalability.
Kneat (TSX: KSI; OTCQX: KSIOF) will release first-quarter 2026 financial results for the quarter ended March 31, 2026, after TSX market close on May 13, 2026. A webcast conference call with CEO Eddie Ryan and CFO Dave O’Reilly will follow on May 14, 2026 at 09:00 ET (14:00 GMT).
According to the company, the webcast registration and the Q1 2026 results will be available in the Financial Information section of the Kneat Investors page at kneat.com/investors.
Kneat (OTCQX: KSIOF) released its 2025 shareholder letter highlighting resilient growth amid industry headwinds. The company reported software revenue +33% in 2025, $74M+ Annual Recurring Revenue and a Net Revenue Retention of 115%.
Kneat cited record new customers, 100% retention among core strategic customers, AI features for GxP environments, a 98/100 G2 satisfaction score, and an NPS above 70. Management expects improving operating efficiency and a path to cash-flow breakeven in 2026.
Kneat (OTCQX: KSIOF) reported record fourth-quarter and full-year 2025 results, with total revenue of $17.0M Q4 (+24% YoY) and $63.3M for 2025 (+29% YoY). ARR reached $74.1M at year-end (+24% YoY). Gross margin improved to 76–78%, Adjusted EBITDA was $9.5M for 2025, and net loss narrowed to $2.3M.
The company highlighted record new customer wins, strategic partnerships (Capgemini), AI product enhancements, leadership changes, and a 2026 target of cash-flow breakeven while anticipating typical second-half seasonality.
Kneat (TSX: KSI / OTCQX: KSIOF) announced a signed Master Services Agreement with a U.S.-headquartered global pharmaceutical packaging and drug-delivery manufacturer on Feb 19, 2026. The customer operates >45 manufacturing sites, including >12 GMP-regulated facilities, and employs over 13,000 people worldwide.
Under the agreement the customer will initially deploy Kneat Gx for CQV at a lead site, with planned expansion to all GMP sites, citing Kneat’s data integrity and audit-ready capabilities as decisive.
Kneat (OTCQX: KSIOF, TSX: KSI) said it will release fourth-quarter and full-year 2025 financial results after TSX close on February 25, 2026. A webcasted conference call and Q&A with CEO Eddie Ryan and CFO Dave O’Reilly is scheduled for February 26, 2026 at 09:00 ET (14:00 GMT).
Financial results will be posted in the Financial Information section of Kneat’s investors page at https://kneat.com/investors/.